Analysed ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ) News Sources
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success
21-07-2026
yahoo.com
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial
01-08-2026
yahoo.com
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
10-08-2026
yahoo.com
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
17-08-2026
yahoo.com
Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma
08-05-2026
yahoo.com
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
18-05-2026
yahoo.com
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
11-06-2026
yahoo.com
What is the current price of ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ)?
The current price of ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ) is $4.12.
ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ) since the previous trading day is $0.23.
ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ) since the previous trading day is 5.9126%.
What is the most recent average sentiment score for ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ)?
The most recent average sentiment score for ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ)?
The most recent sentiment for ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ) is .
SEC-8K** Filing Available For ALPHA TAU MEDICAL LTD -27 (DRTSW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.